In accordance with our results, previous studies demonstrated that inhibition of EphA2 overexpression by siRNA knockdown or blocking antibody could lead to decreased malignant cellular behavior or progression in a variety of cancer cells [12,17,19–21]. Here, EPHA2 is linked to cancer.